Teladoc Health, Inc. (TDOC) — SEC Filings

Latest SEC filings for Teladoc Health, Inc. (TDOC), explained in plain English.

Sentiment Overview: 40 neutral

Recent Filings (40)

• 8-K Filing — 8-K · 2025-12-16T00:00:00.000Z [neutral]
• 8-K Filing — 8-K · 2025-12-12T00:00:00.000Z [neutral]
• 10-Q Filing — 10-Q · 2025-10-30T00:00:00.000Z [neutral]
• 8-K Filing — 8-K · 2025-10-29T00:00:00.000Z [neutral]
• 8-K Filing — 8-K · 2025-10-23T00:00:00.000Z [neutral]
• Teladoc Health Files Q2 2025 10-Q Report — 10-Q · 2025-07-30T00:00:00.000Z [neutral] Risk: medium
  Teladoc Health, Inc. filed its quarterly report for the period ending June 30, 2025. The company's principal executive offices are located at 155 E 44th Street,
• Teladoc Health Files 8-K on Financials — 8-K · 2025-07-29T00:00:00.000Z [neutral] Risk: low
  Teladoc Health, Inc. filed an 8-K on July 29, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and
• Teladoc Health Enters Material Agreement, Triggers Financial Obligation — 8-K · 2025-07-23T00:00:00.000Z [neutral] Risk: medium
  On July 17, 2025, Teladoc Health, Inc. entered into a material definitive agreement, likely related to financing or a significant operational change. This event
• Teladoc Health Files 8-K on Officer Changes and Shareholder Votes — 8-K · 2025-05-23T00:00:00.000Z [neutral] Risk: medium
  Teladoc Health, Inc. filed an 8-K on May 23, 2025, reporting on the departure of directors or certain officers, the election of directors, the appointment of ce
• Teladoc Health Files Proxy Materials — DEFA14A · 2025-05-05T00:00:00.000Z [neutral] Risk: low
  Teladoc Health, Inc. filed a Definitive Additional Materials proxy statement on May 5, 2025. This filing is related to the company's proxy materials and does no
• Teladoc Health Files Q1 2025 10-Q — 10-Q · 2025-05-01T00:00:00.000Z [neutral] Risk: medium
  Teladoc Health, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details the company's financial position and operational performance during
• Teladoc Health Files 8-K on Financials — 8-K · 2025-04-30T00:00:00.000Z [neutral] Risk: low
  Teladoc Health, Inc. filed an 8-K on April 30, 2025, reporting on its Results of Operations and Financial Condition. The filing includes financial statements an
• Teladoc Health DEF 14A: Executive Pay & Governance Details — DEF 14A · 2025-04-08T00:00:00.000Z [neutral] Risk: medium
  Teladoc Health, Inc. filed its DEF 14A on April 8, 2025, detailing executive compensation and corporate governance for the fiscal year ending December 31, 2024.
• Teladoc Health Files 2024 10-K — 10-K · 2025-02-27T00:00:00.000Z [neutral] Risk: medium
  Teladoc Health, Inc. filed its 2024 10-K on February 27, 2025, reporting on its fiscal year ending December 31, 2024. The company, formerly known as Teladoc, In
• Teladoc Health Files 8-K on Financials — 8-K · 2025-02-26T00:00:00.000Z [neutral] Risk: low
  Teladoc Health, Inc. filed an 8-K on February 26, 2025, reporting on its results of operations and financial condition. The filing also includes financial state
• SC 13G/A Filing — SC 13G/A · 2024-11-12T00:00:00.000Z [neutral]
• Teladoc Health Files Q3 2024 10-Q — 10-Q · 2024-10-31T00:00:00.000Z [neutral] Risk: medium
  Teladoc Health, Inc. filed its 10-Q for the period ending September 30, 2024. The filing details financial performance and operational updates for the third qua
• Teladoc Health Relocates Principal Executive Offices — 8-K · 2024-10-30T00:00:00.000Z [neutral] Risk: low
  On October 30, 2024, Teladoc Health, Inc. filed an 8-K report. The filing indicates a change in the company's principal executive offices to 2 Manhattanville Ro
• SC 13G/A Filing — SC 13G/A · 2024-10-23T00:00:00.000Z [neutral]
• Teladoc Health Appoints New Director, Adjusts CMO Compensation — 8-K · 2024-10-01T00:00:00.000Z [neutral] Risk: medium
  Teladoc Health, Inc. announced on September 27, 2024, changes in its board of directors and executive compensation. Specifically, the company elected a new dire
• Teladoc Health Announces Executive Changes and New Board Member — 8-K · 2024-09-09T00:00:00.000Z [neutral] Risk: medium
  Teladoc Health, Inc. announced on September 9, 2024, the departure of its Chief Medical Officer, Dr. David M. Schreiner, effective September 6, 2024. The compan
• SC 13G Filing — SC 13G · 2024-09-05T00:00:00.000Z [neutral]
• Teladoc Health Files Q2 2024 10-Q — 10-Q · 2024-08-01T00:00:00.000Z [neutral] Risk: medium
  Teladoc Health, Inc. filed its 10-Q for the period ending June 30, 2024. The filing details financial performance and operational updates for the second quarter
• Teladoc Health Files 8-K with Financial Updates — 8-K · 2024-07-31T00:00:00.000Z [neutral] Risk: medium
  On July 31, 2024, Teladoc Health, Inc. filed an 8-K report detailing its financial results and operations. The filing includes financial statements and exhibits
• SC 13G/A Filing — SC 13G/A · 2024-07-08T00:00:00.000Z [neutral]
• Teladoc Health Announces Board and Executive Changes — 8-K · 2024-07-05T00:00:00.000Z [neutral] Risk: medium
  Teladoc Health, Inc. announced on June 28, 2024, changes in its board of directors and executive compensation. The filing details the departure of certain offic
• Teladoc Appoints New CFO, Charles Schneider — 8-K · 2024-06-10T00:00:00.000Z [neutral] Risk: medium
  Teladoc Health, Inc. announced on June 5, 2024, the appointment of Charles R. "Chuck" Schneider as its new Chief Financial Officer, effective June 10, 2024. Sch
• Teladoc Health Files 8-K on Shareholder Votes — 8-K · 2024-05-24T00:00:00.000Z [neutral] Risk: low
  Teladoc Health, Inc. filed an 8-K on May 23, 2024, to report on matters submitted to a vote of its security holders. The filing does not contain specific detail
• Teladoc Health Files Q1 2024 10-Q — 10-Q · 2024-04-26T00:00:00.000Z [neutral] Risk: medium
  Teladoc Health, Inc. filed its 10-Q for the period ending March 31, 2024. The filing details financial performance and operational updates for the first quarter
• Teladoc Health Files 8-K on Financials — 8-K · 2024-04-25T00:00:00.000Z [neutral] Risk: low
  Teladoc Health, Inc. filed an 8-K on April 25, 2024, reporting on its results of operations and financial condition. The filing includes financial statements an
• Teladoc Health Appoints Cisco CEO Chuck Robbins to Board — 8-K · 2024-04-12T00:00:00.000Z [neutral] Risk: low
  Teladoc Health, Inc. announced on April 8, 2024, the appointment of Charles R. "Chuck" Robbins as a new Class II director, effective immediately. Robbins, the C
• Teladoc Health DEF 14A: Executive Equity Awards Detailed — DEF 14A · 2024-04-09T00:00:00.000Z [neutral] Risk: medium
  Teladoc Health, Inc. filed its DEF 14A on April 9, 2024, for the fiscal year ending December 31, 2023. The filing details executive compensation, including repo
• Teladoc Health Appoints New CMO, Reports Preliminary Q1 Revenue — 8-K · 2024-04-05T00:00:00.000Z [neutral] Risk: medium
  On April 5, 2024, Teladoc Health, Inc. filed an 8-K report detailing the departure of Chief Medical Officer Dr. Lewis J. Silverman and the appointment of Dr. Mi
• Teladoc Health Files 2023 10-K, Details Annual Performance — 10-K · 2024-02-23T00:00:00.000Z [neutral] Risk: medium
  Teladoc Health, Inc. filed its 10-K on February 23, 2024, for the fiscal year ended December 31, 2023. The filing details the company's financial performance an
• Teladoc Health Files 8-K on Operations and Financial Condition — 8-K · 2024-02-20T00:00:00.000Z [neutral] Risk: low
  Teladoc Health, Inc. filed an 8-K on February 20, 2024, to report on its results of operations and financial condition, as well as to include financial statemen
• SC 13G/A Filing — SC 13G/A · 2024-02-13T00:00:00.000Z [neutral]
• SC 13G/A Filing — SC 13G/A · 2024-02-13T00:00:00.000Z [neutral]
• Sumitomo Mitsui Trust Holdings Updates Teladoc Health Stake — SC 13G/A · 2024-02-05T00:00:00.000Z [neutral]
  Sumitomo Mitsui Trust Holdings, Inc. (SMTH) filed an Amendment No. 2 to its Schedule 13G for Teladoc Health, Inc. (TDOC) on February 5, 2024, indicating its own
• ARK Investment Management Discloses 21.2M Teladoc Shares — SC 13G/A · 2024-01-29T00:00:00.000Z [neutral]
  ARK Investment Management LLC, led by Cathie Wood, filed an amended SC 13G/A on January 29, 2024, disclosing its ownership of Teladoc Health, Inc. common stock
• BlackRock Amends Teladoc Health Stake as of Dec 31, 2023 — SC 13G/A · 2024-01-26T00:00:00.000Z [neutral]
  BlackRock Inc. filed an amended SC 13G/A on January 26, 2024, indicating its ownership of Teladoc Health Inc. common stock as of December 31, 2023. This filing,